Related Experiment Video
Updated: Jun 3, 2026

5/6 Nephrectomy Using Sharp Bipolectomy Via Midline Laparotomy in Rats
Published on: April 4, 2025
[Treatment of gout in patients with chronic kidney disease]
J Bertrand1, S Genevay, P Saudan
1Service de médecine interne générale, HUG, 1211 Genève 14.
Insights
Hyperuricemia and gout are common in kidney patients, posing treatment challenges. Steroids are effective for gout, while adapted-dose allopurinol treats gout but not hyperuricemia prevention.
Area of Science:
- Nephrology
- Rheumatology
- Pharmacology
Context:
- Hyperuricemia and gout frequently affect patients with chronic kidney disease (CKD) and renal transplants.
- Standard hyperuricemia and gout treatments may be contraindicated or cause adverse effects in this population.
- There is a lack of clear therapeutic guidelines for managing hyperuricemia and gout in CKD patients.
Purpose:
- To review the therapeutic landscape of hyperuricemia and gout in patients with chronic kidney disease.
- To evaluate the safety and efficacy of available treatments in this specific patient group.
Summary:
- Steroids are identified as a more effective and safer treatment option for gout in CKD patients, especially when infection is absent.
- Allopurinol, while not recommended for hyperuricemia prophylaxis, is considered a cornerstone treatment for gout in this population.
- Adapted posology of allopurinol is crucial for tolerability and effectiveness in CKD patients with gout.
Impact:
- This review aims to inform clinical practice and guide therapeutic decisions for hyperuricemia and gout management in CKD patients.
- Highlights the need for evidence-based guidelines tailored to the unique challenges of this patient subset.
- Emphasizes the importance of individualized treatment approaches considering patient-specific factors and drug safety profiles.
Abstract:
Hyperuricemia and its clinical manifestations, such as gout, are frequently encountered in patients with chronic renal disease and renal transplants. Usual treatments are either contraindicated or are prone to side-effects in these patients. Presently, there is no clear concensus regarding therapeutic guidelines of hyperuricemia and gout in this subset of patients. Steroids remain the more effective and safer treatment in absence of superimposed infection. Though allopurinol is not recommended for prophylaxis of hyperuricemia, this drug is still the cornerstone in the treatment of patients suffering from gout and is rather well tolerated when posology is adapted.
Related Concept Videos
Chronic Kidney Disease III: Interprofessional Care
Chronic Kidney Disease IV: Nursing Management
Acute Kidney Injury V: Interprofessional Care
Chronic Kidney Disease II: Clinical Manifestations
Urinary Tract Calculi III: Medical Management
Acute Kidney Injury IV: Diagnostic Studies and Prevention
